{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:01:05Z","timestamp":1773788465775,"version":"3.50.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 260\/01\/2022"],"award-info":[{"award-number":["RC 260\/01\/2022"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>This study assessed humoral and T cell-mediated immune responses to the BNT162b2 vaccine in orthotopic liver transplant (OLT) and lung transplant (LUT) recipients who received three doses of the vaccine from March 2021 at our institution. Serum samples were collected 60\u00a0days post-second and third dose to quantify antibodies against the spike region of SARS-CoV-2 while whole blood samples were collected to analyze the SARS-CoV-2-specific T-cell response using an IFN-\u03b3 ELISpot assay. We enrolled 244 OLT and 120 LUT recipients. The third dose increased antibody titres in OLT recipients (from a median value of 131 after the second dose to 5523 IU\/mL, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and LUT recipients (from 14.8 to 1729 IU\/mL, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). T-cell response also increased in OLT recipients (from 8.5 to 23 IFN-\u03b3 SFU per 250,000 PBMC, <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and LUT recipients (from 8 to 15 IFN-\u03b3 SFU per 250,000 PBMC, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). A total of 128 breakthrough infections were observed: two (0.8%) OLT recipients were hospitalized due to COVID-19 and one died (0.4%); among LUT recipients, seven were hospitalized (5.8%) and two patients died (1.7%). In conclusion, the three-dose schedule of the BNT162b2 vaccine elicited both humoral and T cell-mediated responses in solid organ transplant recipients. The risk of severe COVID-19 post-vaccination was low in this population.<\/jats:p>","DOI":"10.3389\/ti.2024.12729","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:11:25Z","timestamp":1720584685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine"],"prefix":"10.3389","volume":"37","author":[{"given":"Letizia Corinna","family":"Morlacchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Alicandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Uceda Renteria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunzio","family":"Zignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Giacomel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Sagasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Citterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Dibenedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Lampertico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferruccio","family":"Ceriotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Francesca","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e068632","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of Covid-19 Vaccines in Immunocompromised Patients: Systematic Review and Meta-Analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low Immunogenicity to SARS-CoV-2 Vaccination Among Liver Transplant Recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2021.12339","article-title":"Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses","volume":"326","author":"Benotmane","year":"2021","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic Lung Allograft Dysfunction: Definition, Diagnostic Criteria, and Approaches to Treatment-A Consensus Report From the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.15585\/mmwr.mm7021e3","article-title":"COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v057.i13","article-title":"Linear Quantile Mixed Models: The Lqmm Package for Laplace Quantile Regression","volume":"57","author":"Geraci","year":"2014","journal-title":"J Stat Softw"},{"key":"B9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cid\/ciq104","article-title":"Humoral Response to the Influenza A H1N1\/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients","volume":"52","author":"Manuel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e13926","DOI":"10.1111\/tid.13926","article-title":"Humoral and Cellular Response of COVID-19 Vaccine Among Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis","volume":"24","author":"Meshram","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/microorganisms10051021","article-title":"Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort","volume":"10","author":"Giannella","year":"2022","journal-title":"Microorganisms"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1111\/ajt.16818","article-title":"Cellular Immunity Predominates over Humoral Immunity After Homologous and Heterologous mRNA and Vector-Based COVID-19 Vaccine Regimens in Solid Organ Transplant Recipients","volume":"21","author":"Schmidt","year":"2021","journal-title":"Am J Transpl"},{"key":"B13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jhep.2022.03.042","article-title":"A Third Dose of the BNT162b2 mRNA Vaccine Significantly Improves Immune Responses Among Liver Transplant Recipients","volume":"77","author":"Davidov","year":"2022","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1016\/j.cgh.2022.06.028","article-title":"Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients","volume":"20","author":"Harberts","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"880784","DOI":"10.3389\/fimmu.2022.880784","article-title":"Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals","volume":"13","author":"Paramithiotis","year":"2022","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijid.2021.09.073","article-title":"Performance of the T-SPOT\u24c7.COVID Test for Detecting SARS-CoV-2-Responsive T Cells","volume":"113","author":"Kruse","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1586\/erv.10.169","article-title":"ELISpot for Measuring Human Immune Responses to Vaccines","volume":"10","author":"Slota","year":"2011","journal-title":"Expert Rev Vaccin"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0189488","DOI":"10.1371\/journal.pone.0189488","article-title":"Cytomegalovirus (CMV) Immune Monitoring With ELISPOT and QuantiFERON-CMV Assay in Seropositive Kidney Transplant Recipients","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.4049\/jimmunol.170.9.4833","article-title":"Inhibition of IFN-Gamma Signaling by Glucocorticoids","volume":"170","author":"Hu","year":"2003","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41598-021-86053-0","article-title":"Low-Dose Steroids Are Associated With Indeterminate QuantiFERON-TB Gold In-Tube Assay Results in Immunocompetent Children","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16455","DOI":"10.20452\/pamw.16455","article-title":"Seroconversion Following a Booster Dose of COVID-19 Vaccine in Liver Transplant Recipients: A Systematic Review and Meta-Analysis","volume":"133","author":"Gkoufa","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/biomedicines11061540","article-title":"Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab\/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients","volume":"11","author":"Lombardi","year":"2023","journal-title":"Biomedicines"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3390\/biomedicines10082002","article-title":"Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study","volume":"10","author":"Biscarini","year":"2022","journal-title":"Biomedicines"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/cid\/ciad016","article-title":"Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort","volume":"76","author":"Bonazzetti","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/ajt.17117","article-title":"The Risk and Consequences of Breakthrough SARS-CoV-2 Infection in Solid Organ Transplant Recipients Relative to Non-Immunosuppressed Controls","volume":"22","author":"Vinson","year":"2022","journal-title":"Am J Transpl"},{"key":"B27","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.2021.1375","article-title":"Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines","volume":"325","author":"Livingston","year":"2021","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.medj.2020.12.006","article-title":"A Booster Dose Enhances Immunogenicity of the COVID-19 Vaccine Candidate ChAdOx1 nCoV-19 in Aged Mice","volume":"2","author":"Silva-Cayetano","year":"2021","journal-title":"Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0264-410x(95)00209-j","article-title":"Immune Response to a Booster Dose of Enhanced Potency Inactivated Polio Vaccine Administered in Association With HBV Vaccine in Adolescents","volume":"14","author":"Pregliasco","year":"1996","journal-title":"Vaccine"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12729\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:11:30Z","timestamp":1720584690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12729\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":28,"alternative-id":["10.3389\/ti.2024.12729"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.12729","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"article-number":"12729"}}